Concern "Belbiopharm" made to the Ministry of Economy of Belarus suggestions for increasing the prices of medicines in Belarus.
About This was announced Interfax representative office.
"There is a proposal for a fairly wide range of drugs that produce the companies belonging to a group and the prices of which are regulated by the state.
Group seeks to minimize the costs associated with the devaluation of the official exchange rate Belarusian ruble, because the majority of Belarusian drug has a fairly high proportion of imported raw materials, "- said the official.
He noted that the Ministry of Economy in these circumstances is going to provide the smallest possible increase in retail prices, including by reducing the level of profitability of pharmaceutical companies. However, "for some items, for example, where a portion of imported raw materials is 90%, a sharp rise in prices can not be avoided."